2nd Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$78,690
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy for funding of Bioshield Special Reserve Fund (SRF) as authorized in the Pandemic and All-Hazards Preparedness Reauthorization Act 2013. Advocacy for funding of BARDA at HHS. Education of House and Senate staff on anthrax recombinant protective antigen vaccine and recombinant butyrlcholinesterase as an organophosphate bioscavneger for chemical nerve agent prophylaxis.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP Policy and Government Affairs
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.